Crescent Pharma Limited has issued a recall of one batch of Ramipril 10mg capsules. The recall is being carried out as a precautionary measure following the identification of a potential error at the manufacturing site. The Medicines and Healthcare products Regulatory Agency (MHRA) has been notified of the recall.
Cập nhật pháp chế23 thg 8, 2026•1 phút đọc
Crescent Pharma Recalls Ramipril 10mg Capsules Batch
Crescent Pharma Limited is recalling a batch of Ramipril 10mg capsules as a precaution due to a possible manufacturing error.
Tổng hợp bởi đội ngũ PharmaCountry · Nguồn: MHRA
Đánh giá
(0)
(0)
(0)
(0)
(0)
Bài viết khác
Xem tất cả bài viếtNghiên cứu & Báo cáo
Global Finished Dosage Manufacturing Landscape 2026
5 thg 10, 2026
Cập nhật pháp chếKorea Korus hit with 1‑month manufacturing suspension over missing post‑marketing safety test
28 thg 9, 2026
Phân tíchPharma distributors set delivery cut‑offs ahead of Chuseok holiday (Sep 21‑23)
28 thg 9, 2026
Để lại đánh giá